Caris Life Sciences (CAI) Equity Ratio (2024 - 2026)

Caris Life Sciences' Equity Ratio history runs 3 years deep, the most recent figure standing at 0.51 for Q1 2026.

• In Q1 2026, Equity Ratio changed N/A year-over-year to 0.51; the TTM figure through Mar 2026 stood at 0.51 (changed N/A YoY), while the FY2025 annual figure was 0.51, up 107.05% from the prior year.
• Equity Ratio was 0.51 for Q1 2026 at Caris Life Sciences, roughly flat from 0.51 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.51 in Q4 2025 to a low of 7.27 in Q4 2024.
• Historically, Equity Ratio has averaged 1.06 across 3 years, with a median of 0.49 in 2025.
• Biggest YoY gain for Equity Ratio was 107.05% in 2025; the steepest drop was 107.05% in 2025.
• A 3-year view of Equity Ratio shows it stood at 7.27 in 2024, then surged by 107.05% to 0.51 in 2025, then retreated by 0.44% to 0.51 in 2026.
• The last three Equity Ratio figures came in at 0.51 (Q1 2026), 0.51 (Q4 2025), and 0.49 (Q3 2025), per Business Quant data.